Dmitriy Zamarin, MD, PhD

Assistant Attending Physician

Dmitriy Zamarin, MD, PhD

Office Phone


Lab Phone


Genetically-engineered oncolytic viruses are an emerging class of cancer therapeutics which have shown significant clinical promise in the recent years. My research focuses on exploration of oncolytic viruses for cancer immunotherapy.  Specifically, I am using engineered Newcastle Disease Virus (NDV) to study the mechanisms of anti-tumor immunity induced by viruses and to develop novel anti-cancer agents. My main area of interest is exploring different immunotherapeutic strategies that could circumvent the limitations of oncolytic viruses and make oncolytic virus-based therapy applicable to all cancer types.